Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.
Find out what a historical investment in ProMIS Neurosciences Inc would be worth today using our PMN stock calculator.
Buying PMN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ProMIS Neurosciences Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PMN
What is the ticker symbol of ProMIS Neurosciences Inc?
The ticker symbol for ProMIS Neurosciences Inc is PMN.
How much is one share of PMN?
One share of PMN is valued at $3.21 as of 20 November 2026.
What is the market capitalisation of ProMIS Neurosciences Inc PMN?
As of 20 November 2026 ProMIS Neurosciences Inc has a market cap of $28.16M.
What is the 52-week high for ProMIS Neurosciences Inc stock?
The ProMIS Neurosciences Inc 52-week high stock price is $27.40.
What is the 52-week low for ProMIS Neurosciences Inc stock?
The ProMIS Neurosciences Inc 52-week low stock price is $2.78.
Can I buy PMN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PMN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PMN on Stake
Buy PMN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PMN from only US$10 with fractional shares